Bree B. Aldridge

5.1k total citations
45 papers, 2.4k citations indexed

About

Bree B. Aldridge is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Bree B. Aldridge has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 18 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in Bree B. Aldridge's work include Tuberculosis Research and Epidemiology (27 papers), Mycobacterium research and diagnosis (17 papers) and Antibiotic Resistance in Bacteria (10 papers). Bree B. Aldridge is often cited by papers focused on Tuberculosis Research and Epidemiology (27 papers), Mycobacterium research and diagnosis (17 papers) and Antibiotic Resistance in Bacteria (10 papers). Bree B. Aldridge collaborates with scholars based in United States, France and Türkiye. Bree B. Aldridge's co-authors include Peter K. Sorger, Douglas A. Lauffenburger, John M. Burke, Sarah M. Fortune, John G. Albeck, Mingsheng Zhang, Marta Fernández-Suárez, Jonah Larkins‐Ford, Mehmet Toner and Danielle M. Heller and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Bree B. Aldridge

44 papers receiving 2.3k citations

Peers

Countries citing papers authored by Bree B. Aldridge

Since Specialization

Citations

This map shows the geographic impact of Bree B. Aldridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bree B. Aldridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bree B. Aldridge more than expected).

Fields of papers citing papers by Bree B. Aldridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bree B. Aldridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bree B. Aldridge. The network helps show where Bree B. Aldridge may publish in the future.

Co-authorship network of co-authors of Bree B. Aldridge

This figure shows the co-authorship network connecting the top 25 collaborators of Bree B. Aldridge. A scholar is included among the top collaborators of Bree B. Aldridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bree B. Aldridge. Bree B. Aldridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy 2025 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), Pauline Maiello, H. Jacob Borish, (unknown), (unknown), Mark Rodgers, Jaime Tomko, Philana Ling Lin, (unknown), Bree B. Aldridge, Denise E. Kirschner	0
2	Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data 2025 ·iScience ·(unknown), (unknown), (unknown), Rob C. van Wijk, Natasha Strydom, Qianwen Wang, (unknown), (unknown), Eric L. Nuermberger, Bree B. Aldridge, (unknown), Jansy P. Sarathy, Véronique Dartois, Rada Savic	1
3	Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses 2024 ·mBio ·(unknown), (unknown), (unknown), Ryan Peters, (unknown), Joan Mecsas, Bree B. Aldridge	4
4	Single-cell imaging of the Mycobacterium tuberculosis cell cycle reveals linear and heterogenous growth 2024 ·Nature Microbiology ·Eun Seon Chung, (unknown), (unknown), Ariel Amir, Bree B. Aldridge	5
5	Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus 2023 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), Jonah Larkins‐Ford, Jacob A. Klickstein, Florian P. Maurer, David Stone, (unknown), Cheleste M. Thorpe, (unknown), Bree B. Aldridge	8
6	Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis 2023 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Bree B. Aldridge	8
7	C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus 2022 ·PNAS Nexus ·(unknown), Katherine S. H. Beckham, Matt D. Johansen, Laura Berneking, (unknown), (unknown), (unknown), Flor Vásquez Sotomayor, (unknown), Holger Rohde, Bree B. Aldridge, Martin Aepfelbacher, Annabel Parret, Matthias Wilmanns, Laurent Kremer, Keith D. Combrink, Florian P. Maurer	9
8	Tuberculosis treatment failure associated with evolution of antibiotic resilience 2022 ·Science ·Qingyun Liu, Junhao Zhu, Charles L. Dulberger, Sydney Stanley, Sean Wilson, Eun Seon Chung, Xin Wang, Peter H. Culviner, (unknown), Nathan Hicks, Gregory H. Babunovic, (unknown), Bree B. Aldridge, Ethan C. Garner, Eric J. Rubin, Michael C. Chao, Sarah M. Fortune	46
9	Localization of EccA3 at the growing pole in Mycobacterium smegmatis 2022 ·BMC Microbiology ·(unknown), Mae Newton-Foot, (unknown), Bree B. Aldridge, Carolina Mehaffy, John T. Belisle, Gerhard Walzl, Robin M. Warren, Samantha L. Sampson, Nicolaas C. Gey van Pittius	4
10	Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits 2021 ·Antimicrobial Agents and Chemotherapy ·Oluwaseun Francis Egbelowo, Jansy P. Sarathy, (unknown), Matthew Zimmerman, Han Wang, (unknown), Firat Kaya, Martin Gengenbacher, (unknown), (unknown), Carol A. Nacy, Bree B. Aldridge, Claire L. Carter, Paolo Denti, Véronique Dartois	17
11	Leveraging laboratory and clinical studies to design effective antibiotic combination therapy 2021 ·Current Opinion in Microbiology ·(unknown), (unknown), Roberto Viau, Bree B. Aldridge	7
12	Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis 2021 ·Cell Systems ·Jonah Larkins‐Ford, (unknown), (unknown), (unknown), (unknown), Artem Sokolov, Bree B. Aldridge	41
13	Morphological profiling of tubercle bacilli identifies drug pathways of action 2020 ·Proceedings of the National Academy of Sciences ·(unknown), Krista M. Pullen, (unknown), (unknown), (unknown), (unknown), Jonah Larkins‐Ford, Xin Wang, Joel S. Freundlich, D. Michael Ando, Bree B. Aldridge	31
14	Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis 2019 ·mBio ·Shuyi Ma, (unknown), Jonah Larkins‐Ford, (unknown), Bree B. Aldridge, David R. Sherman, Sriram Chandrasekaran	40
15	Prediction of ultra-high-order antibiotic combinations based on pairwise interactions 2019 ·PLoS Computational Biology ·Itay Katzir, Murat Cokol, Bree B. Aldridge, Uri Alon	50
16	Stable Regulation of Cell Cycle Events in Mycobacteria: Insights From Inherently Heterogeneous Bacterial Populations 2018 ·Frontiers in Microbiology ·(unknown), Bree B. Aldridge	27
17	Rv0004 is a new essential member of the mycobacterial DNA replication machinery 2017 ·PLoS Genetics ·Katherine Mann, (unknown), (unknown), (unknown), (unknown), (unknown), Jacqueline M. Kimmey, Bree B. Aldridge, Christina L. Stallings	19
18	Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility 2011 ·Science ·Bree B. Aldridge, Marta Fernández-Suárez, Danielle M. Heller, (unknown), Daniel Irimia, Mehmet Toner, Sarah M. Fortune	318
19	Fuzzy Logic Analysis of Kinase Pathway Crosstalk in TNF/EGF/Insulin-Induced Signaling 2009 ·PLoS Computational Biology ·Bree B. Aldridge, Julio Sáez-Rodríguez, Jeremy L. Muhlich, Peter K. Sorger, Douglas A. Lauffenburger	116
20	Direct Lyapunov exponent analysis enables parametric study of transient signalling governing cell behaviour 2006 ·PubMed ·Bree B. Aldridge, George Haller, Peter K. Sorger, D. A. Lauffenburger	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact